Selective Genetics, Inc.
San Diego, CA, US· latest recorded location
Selective Genetics, Inc. is named on 12 US grants and 8 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 12
- Published applications
- 8
- Inventors
- 18
- Granted in 2026 so far
- 0
- Most recent grant
- 12 Dec 2006
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 2 |
| 2003 | 4 | 4 |
| 2004 | 1 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
By publication year.
Technology areas
Share of 20 documents
- C12NMicroorganisms or enzymes19
- A61KMedicines and medical preparations17
- C07KPeptides14
- A61PTherapeutic uses of medicines9
- C40BCombinatorial chemistry9
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3
- A61LMethods or apparatus for sterilising materials or objects in general1
Recent patents
- Receptor-mediated gene delivery using bacteriophage vectors12 Dec 2006US 7,148,202 B2
- Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors20 Apr 2004US 6,723,512 B2
- Methods for identifying protein-protein interactions by selective transduction8 Jul 2003US 6,589,730 B1
- Compositions and methods for delivery of agents for neuronal regeneration and survival22 Apr 2003US 6,551,618 B2
- Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby25 Mar 2003US 6,537,813 B1
- Devices containing DNA encoding neurotrophic agents and related compositions and methods15 Jul 2004US 2004/0138155 A1
- Viral vectors with modified tropism12 Feb 2004US 2004/0029280 A1
- Methods and compositions using genetic package display7 Aug 2003US 2003/0148263 A1
- Traversal of nucleic acid molecules through a fluid space and expression in repair cells7 Aug 2003US 2003/0148979 A1
- Compositions containing nucleic acids and ligands for therapeutic treatment31 Jul 2003US 2003/0143217 A1
Most cited
By later US patents
- Receptor-mediated gene delivery using bacteriophage vectors63US 6,054,312 A2000
- Compositions containing nucleic acids and ligands for therapeutic treatment50US 6,037,329 A2000
- Compositions and methods for delivery of agents for neuronal regeneration and survival50US 6,551,618 B22003
- Methods using genetic package display for selecting internalizing ligands for gene delivery34US 6,451,527 B12002
- Stabilized nucleic acid compositions and methods of preparation and use thereof31US 6,251,599 B12001